Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

DMAC

DiaMedica Therapeutics (DMAC)

DiaMedica Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DMAC
DateTimeSourceHeadlineSymbolCompany
11/13/20234:52PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
11/13/20234:28PMBusiness WireDiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
11/09/20238:25AMBusiness WireDiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
11/06/20238:23AMBusiness WireDiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
09/12/20238:13AMBusiness WireDiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology OfficerNASDAQ:DMACDiaMedica Therapeutics Inc
09/06/20238:35AMBusiness WireDiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
09/05/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
08/14/20234:29PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DMACDiaMedica Therapeutics Inc
08/14/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
08/14/20234:13PMBusiness WireDiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
08/08/20238:32AMBusiness WireDiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
07/18/20238:30AMBusiness WireDiaMedica Therapeutics to Attend the American Academy of Neurology Summer ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
07/10/20234:16PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DMACDiaMedica Therapeutics Inc
07/10/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DMACDiaMedica Therapeutics Inc
06/30/20234:16PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DMACDiaMedica Therapeutics Inc
06/27/20234:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
06/27/20234:11PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DMACDiaMedica Therapeutics Inc
06/26/20234:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
06/26/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
06/26/20234:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
06/26/20234:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
06/26/20234:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
06/26/20238:30AMBusiness WireDiaMedica Therapeutics Announces Closing of $37.5 Million Private PlacementNASDAQ:DMACDiaMedica Therapeutics Inc
06/23/20235:14PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DMACDiaMedica Therapeutics Inc
06/23/20235:11PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DMACDiaMedica Therapeutics Inc
06/21/20238:43AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
06/21/20238:39AMBusiness WireDiaMedica Therapeutics Announces $37.5 Million Private PlacementNASDAQ:DMACDiaMedica Therapeutics Inc
06/21/20238:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
06/21/20238:15AMBusiness WireDiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic StrokeNASDAQ:DMACDiaMedica Therapeutics Inc
06/02/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DMAC